Teva has launched a digitally-enabled inhaler in the UK, the first European market for the device, for use by patients with asthma and chronic obstructive pulmonary disorder (COPD). The GoResp ...

People using a blue inhaler to help treat their asthma are being urged to contact their GP. The call comes after changes in guidelines following research which showed long-term use of the medication ...

AstraZeneca has claimed UK approval for a new version of its respiratory triple therapy Trixeo Aerosphere that contains a propellant with a massively reduced global warming potential (GWP). The drug – ...

For decades, the little blue inhaler was a lifeline for millions of people with asthma. But doctors now know it can make the condition worse - and a quiet revolution in treatment is already ...

10:29, Tue, May 5, 2026 Updated: 10:36, Tue, May 5, 2026 Asthma sufferers who rely on a blue inhaler to manage their condition are being advised to speak to their GP. The guidance follows updated ...

Asthma sufferers who rely on a blue inhaler to manage their condition are being urged to speak to their GP. The appeal follows updated guidelines prompted by research indicating that prolonged use of ...

Riker Laboratories advertised its new device for treating asthma in 1957—two years after a teenager’s truly inspiring suggestion. Courtesy Mark Sanders In April 1955, 13-year-old Susie Maison asked ...

Some people with asthma need to use multiple inhaled medicines each day to keep their symptoms under control. The approval of long-acting, combination inhalers that contain more than one medicine is ...

Spiriva (tiotropium bromide) is an anticholinergic medication that relaxes airway muscles to ease breathing in chronic obstructive pulmonary disease (COPD) and asthma. It’s meant for long-term daily ...

Taking Spiriva with other anticholinergic drugs, such as medications for overactive bladder or Parkinson’s disease, can increase the risk of side effects. Spiriva doesn’t interact with alcohol, but ...

The heritage of Boehringer Ingelheim in developing medicines for respiratory diseases spans almost 100 years. Within the respiratory disease area, innovative treatments for chronic obstructive ...

Brits who bank on puffing a blue inhaler to open their airways and ease their breathing have been urged to urgently contact their GP. Millions of people in the UK use them to help alleviate asthma ...